Skip to content

Effectiveness of Fagopyrum in atopic dermatitis

Effectiveness of Fagopyrum esculentum in Atopic dermatitis:A single arm clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051615
Enrollment
35
Registered
2023-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Fagopyrum esculentum: Homoeopathic drugs as detailed in the Homoeopathic Pharmacopoeia (India/US) will be used in the study on the basis of symptom similarity (Homoeopathic principle).

Sponsors

RBTS Govt Homoeo Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Self-reported & pre-diagnosed cases of Atopic dermatitis. Patients with symptomatology of atopic dermatitis

Exclusion criteria

Exclusion criteria: Patients or, its guardian unwilling to take part or not giving consent to join the study Diagnosed cases of systemic diseases, psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure. Substance abuse and/ or dependence. Self-reported immune-compromised state. Undergoing homoeopathic treatment for any chronic disease within the last 6 months.

Design outcomes

Primary

MeasureTime frame
The response and improvement of the patient were observed in cases of atopic dermatitis through marked improvement on boils and eruption in the patientTimepoint: 0-3 Months

Secondary

MeasureTime frame
Assessed by Atopic Dermatitis Severity Index (ADSI)Timepoint: baseline and after 3 months

Countries

India

Contacts

Public ContactDr Vivek Kumar Shail

R B T S Govt Homoeo Medical College and Hospital

drviknih@gmail.com8298994658

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026